Biogen Inc. · BIIB · Next earnings

Biogen Inc. reports Wednesday, Oct 28, 2026

BIIB reports before market open with consensus EPS at $2.03 and revenue at $2.64B. Last quarter: Biogen Beats Q1 Estimates as Growth Products Surge 12% YoY

Reports Before market open38 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $2.03 Calendar consensus
Consensus revenue $2.64B Calendar consensus
Report date Oct 28, 2026 Wednesday, date estimated
Session Before market open 38 days away

Where BIIB left off: FY2026 Q1

Full report

Biogen Beats Q1 Estimates as Growth Products Surge 12% YoY

EPS surprise +17.0% Reported $3.57 vs $3.05
Revenue surprise +8.4% Reported $2.48B vs $2.29B
Stock move +6.0% Event window
Subsequent drift +1.0% Up to 20 sessions

Guidance was maintained. Management reaffirmed the full-year outlook, emphasizing continued investment in R&D and commercial execution alongside disciplined cost management. No upward or downward revision was indicated.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Macro-economic and policy uncertainties, including tariff exposure
  • Integration and execution risk related to the Apellis transaction
  • Dependence on successful regulatory approvals and data readouts for pipeline assets
  • Intensifying competition in Alzheimer's, SMA, ophthalmology, and nephrology markets

Questions analysts left open

  • Timing and signal expectations for BIIB080 phase II/III data
  • Filing strategy for litifilimab in SLE and CLE
  • Competitive landscape and biomarker adoption for SYFOVRE
  • Commercial impact of high-dose SPINRAZA on the broader SMA franchise
  • Integration plan and cost synergies for the Apellis deal

Ask FN2 about BIIB next report

Transcript, numbers and history already loaded
What should I watch for in BIIB's next earnings report?How did BIIB guide last quarter, and is consensus above or below that?Give me the bull and bear case going into BIIB earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the BIIB recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent BIIB quarters

All BIIB earnings
+6.0%FY2026 Q1

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q1

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.